149 related articles for article (PubMed ID: 3753495)
1. Platelet-activating factor in normal rat uterus.
Yasuda K; Satouchi K; Saito K
Biochem Biophys Res Commun; 1986 Aug; 138(3):1231-6. PubMed ID: 3753495
[TBL] [Abstract][Full Text] [Related]
2. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity.
Nakayama R; Yasuda K; Satouchi K; Saito K
Biochem Biophys Res Commun; 1988 Mar; 151(3):1256-61. PubMed ID: 3355555
[TBL] [Abstract][Full Text] [Related]
3. Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry.
Yasuda K; Satouchi K; Nakayama R; Saito K
Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):137-41. PubMed ID: 3242662
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
5. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
6. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress.
Sugatani J; Fujimura K; Miwa M; Satouchi K; Saito K
Lipids; 1991 Dec; 26(12):1347-53. PubMed ID: 1819731
[TBL] [Abstract][Full Text] [Related]
8. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy.
Matsubara T; Yasuda K; Johnston JM; Sanezumi M; Okada H; Matsuoka S; Kanzaki H
Biol Reprod; 1997 Apr; 56(4):885-90. PubMed ID: 9096869
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.
Wykle RL; Malone B; Snyder F
J Biol Chem; 1980 Nov; 255(21):10256-60. PubMed ID: 7430122
[TBL] [Abstract][Full Text] [Related]
11. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection.
Bossant MJ; Farinotti R; Mencia-Huerta JM; Benveniste J; Mahuzier G
J Chromatogr; 1987 Dec; 423():23-31. PubMed ID: 3443654
[TBL] [Abstract][Full Text] [Related]
12. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain.
Tokumura A; Kamiyasu K; Takauchi K; Tsukatani H
Biochem Biophys Res Commun; 1987 May; 145(1):415-25. PubMed ID: 3593346
[TBL] [Abstract][Full Text] [Related]
13. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
14. Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus.
Nakayama R; Yasuda K; Saito K
J Biol Chem; 1987 Sep; 262(27):13174-9. PubMed ID: 3654606
[TBL] [Abstract][Full Text] [Related]
15. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
16. Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells.
Nakayama R; Kumagai H; Saito K
Biochim Biophys Acta; 1994 Mar; 1199(2):137-42. PubMed ID: 8123662
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
Kramer RM; Jakubowski JA; Deykin D
Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
20. Cooperativity between platelet-activating factor and collagen in platelet aggregation.
Kojima S; Hagiwara H; Soga W; Sekiya F; Saito Y; Inada Y
Biochem Biophys Res Commun; 1987 Jun; 145(2):915-20. PubMed ID: 3593379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
